Introduction
The respiratory tract is routinely exposed to low-molecular-weight chemicals and to a variety of many environmental chemical allergens whose inhalation is a leading cause of respiratory diseases, including asthma [1] . The increased pesticide exposure from occupational, environmental or residential usages over the past three decades may have contributed to the higher incidence of asthma, particularly in children from urban areas [2, 3] .
Development of allergic respiratory diseases requires sensitization, which may be triggered by dermal or respiratory exposure to the sensitizing chemical [4] . Airways are also exposed to irritants which are noncorrosive chemicals that cause a reversible inflammatory change of the bronchial mucosa [5 ] . Exposure to either sensitizing or irritant chemicals in the workplace may lead to work-related asthma, a recent term that encompasses both occupational asthma (e.g. asthma induced by sensitizer or irritant work exposures) and work-exacerbated asthma, that is pre-existing or concurrent asthma worsened by work factors, including irritant exposures [6] . When occupational asthma appears after exposure to an inhaled irritant at work, it is termed irritant-induced occupational asthma [6] .
Reactive airways dysfunction syndrome (RADS) can be considered a subset of irritant-induced asthma (IIA) that develops after an unintentional short-term high-level exposure to nonimmunogenic, highly irritating volatile substances. Pesticides are among the most common agents producing RADS [7] . Some of the clinical manifestations are very similar to those of asthma (e.g. inflammation, hyper-responsiveness and reversibility of the bronchial constriction), although this syndrome does not involve immunological mechanisms [8] . The pathomorphologic bronchial biopsies usually show neutrophilic and lymphocytic infiltrations without eosinophilia and some evidence of subepithelial thickening, fibrosis and destruction of the bronchial epithelium [9] . These histopathological findings are partially reversible and not sufficiently distinctive to be helpful in diagnosis [10, 11] .
Pesticide exposure and airways
Exposures to pesticides may cause a wide range of acute or chronic (long-term) health effects, depending on the toxicity of the pesticide and the level of exposure. The biological activity of a pesticide is determined by its active ingredient that is usually formulated with other chemical compounds to improve its physico-chemical properties. Among these chemicals, organic solvents are also relevant to the final toxicity of the commercial formulation. Table 1 shows the most common pesticides and their mode of action and acute toxicity.
Lungs may be exposed to pesticides by inhalation of solid or liquid aerosols (powders, airborne droplets) and vapors. When commercial formulations of pesticides enter into contact with skin and mucous membranes (eyes, nose, airways), a local irritative or inflammatory reaction may appear depending on their physicochemical characteristics. Although the main health risk occurs during mixing/loading of the concentrated formulation, inhalation of aerosols of diluted pesticides during their spraying also possesses risks. In addition, many pesticides give off a vapor when exposed to air; hence, temperature has a major influence on their volatilization rate, mainly through its effect on the vapor pressure. Thus, higher volatility pesticides (i.e. soil fumigants) pose a greater risk for exposure, particularly in enclosed spaces and near application sites [12] .
Most of pesticide poisonings from occupational origin occur through skin contact, followed by the combination of respiratory and cutaneous-mucous exposure (41 and 20% of cases, respectively) causing topical effects in the form of dermatitis or skin irritation [13 ] . In contrast, systemic effects occur away from the original point of contact as a result of the pesticide being absorbed into and distributed throughout the body. Thus, respiratory toxicity (bronchoconstriction, bronchorrhea and wheeze) may occur after cutaneous absorption of anticholinesterase pesticides such as organophosphates and methylcarbamates. More uncommonly, it is possible that the dermal absorbed fraction of the herbicide paraquat may be selectively taken up by the lungs in which it may interact with and damage the alveolar-capillary membrane leading eventually to death [14] .
Several types of pesticides such as organophosphates, chlorophenoxy acid and methylcarbamates have a high risk of causing bronchial asthma-like diseases when they diffuse into the ambient air. However, many diffused pesticides have weak or minimal immunogenicity on the basis of the slight immunomodulatory changes observed in some human immune laboratory parameters [15] . The subtle immune alterations associated with intermittent and low-dose pesticide exposure do not necessarily evolve into significant health risk (namely, asthma) to the exposed individuals.
Epidemiological studies
A few epidemiological studies have examined so far the possible relation between exposure to pesticides (mostly organophosphates or carbamates) and asthma. Asthmalike conditions and/or obstructive ventilatory changes have been reported following either acute or chronic exposure to pesticides.
Although high pesticide exposure events are subtle enough that they do not result in seeking medical advice, they have been associated with an increased risk of both allergic and nonallergic asthma [16] . The occurrence of true pesticide poisoning by organophosphates and pyrethrins can also lead to asthma [17, 18] , particularly as a sequel of acute poisoning. However, according to the US Environmental Protection Agency [19] , there is no clear and consistent association between pyrethroid exposure and asthma and allergies. Persistent irritant-induced asthma has been reported in community residents and individuals occupationally exposed to an environmental spill of the pesticide metam sodium, the most widely used soil fumigant in the US [20] . This compound is a member of the dithiocarbamate family (Table 1) and gives off methyl isothiocyanate vapors after entering into contact with water. Hernández et al. [21] observed a decreased forced expiratory volume in one second (FEV1) in intensive agricultural workers showing a depression in serum cholinesterase more than 25%, indicating that recent (or short-term) exposure to anticholinesterase insecticides is followed by a transient obstructive lung dysfunction, very likely as a result of their prolonged muscarinic effects on large airways. This observation is consistent with previous studies in individuals exposed to anticholinesterase agents [22] who developed bronchoconstriction and further decrease in lung function test.
Chronic exposure to various types of pesticides may aggravate or enhance asthmatic symptoms (wheeze, phlegm, flu-like symptoms), thus making pesticides an overlooked contributor to asthma risk. Application of carbamate insecticides has been associated with a higher prevalence of asthma in male farmers [23] . In the Agriculture Health Study (AHS), Hoppin et al. [24] observed a modest association between wheeze and exposure to paraquat, thiocarbamates and organophosphates in the previous year. A stronger association was reported for organophosphates in farmers and commercial applicators, with chlorpyrifos being strongly associated in a dosedependent manner in both groups. A further study [16] of the AHS cohort reported that certain pesticides were associated with both allergic asthma (coumaphos, heptachlor, parathion and ethylene dibromide, with significant exposure-response trends) and nonallergic asthma (dichlorodiphenyltrichloroethane, DDT); nevertheless, the evidence supporting that allergy alone drives these associations is scarce. Given the variety of pesticides associated with allergic asthma, a major role of some common chemicals included in their formulation cannot be ruled out [16] , and perhaps an aggravation of preexisting asthma may be the rule. Among the farm women included in the AHS, pesticides may contribute to atopic asthma but not nonatopic asthma, although the strength of the association was small [25] . A significant reduction in forced expiratory flow between 25 and 75 percent of vital capacity (FEF ) has been associated with cumulative (long-term) exposure to pesticides and with the occurrence of respiratory symptoms in intensive agricultural workers [21] . This observation suggests that continuous exposure to low levels of pesticide aerosols may affect small airways, very likely causing a chronic inflammatory response responsible for persistent bronchial hyper-responsiveness and peripheral airway obstruction.
Mechanistic studies
Growing evidence from animal models and human epidemiological studies has provided insights into the mechanisms underlying the development and maintenance of asthma following pesticide exposure.
Neurogenic inflammation
Depending on their physicochemical characteristics, pesticide aerosols, gases or vapors may exert a corrosive action on the airways causing a direct damage to the cells of the bronchial mucosa. However, whether they are less corrosive but have irritant properties they may produce neurogenic inflammation by interacting with functional irritant receptors in the airways as occurs with other respiratory irritants.
The airways are innervated by sensory C-fibers expressing specific receptors that can be activated by noxious chemicals contained in the inhaled air [26] . These sensory neurons not only function as afferent fibers collecting information from the environment but also have an efferent function whereby they may be activated locally from within the periphery to release vasoactive sensory neuropeptides (Fig. 1) .
Two major proinflammatory transient receptor potential (TRP) ion channels are expressed in airway chemosensory nerves: TRPV1, the capsaicin receptor, and TRPA1, activated by a broad array of chemical irritants. Agonists of these receptors have been associated with allergic and occupational asthma and RADS [27] . The TPVR1 receptor, formerly known as vanilloid receptor, is activated by various ligand-like agents and different unrelated stimuli such as chemical irritants, inflammatory mediators and nonselective tissue damaging stimuli including heat (>438C), acidic pH (<5.3), intracellular redox states and electrostatic charge [28, 29] . TRPA1 is an irritant-sensing ion channel that also plays a key role in allergic asthma by acting as a major neuronal mediator of allergic airway inflammation [30] . Endogenous TRPA1 agonists, such as reactive oxygen species, hypochlorite and lipid peroxidation products, are potent drivers of allergen-induced airway inflammation in asthma [27] . TRPA1 channels might be also activated by pesticides, either directly (such as other environmental irritant agents) or indirectly by means of the oxidative stress generated by these compounds [22, 31] .
Animal models lacking TRPA1 expression or pharmacological channel inhibition have been associated with fewer asthma symptoms, reduced allergen-induced inflammatory leukocyte infiltration, airway mucus production, cytokine and chemokine levels and airway hyper-reactivity/bronchoconstriction [27] . It has been proposed that human TRPpathies may account for the variability of asthma development upon allergen or chemical challenges [32] .
The inhalation of chemical irritants activates TRP receptors not only on sensory C-fibers but also on some nonneural cells (e.g. respiratory epithelia and inflammatory cells). As a result, proinflammatory peptides (tachykinin neuropeptides, such as substance P, neurokinin A, and calcitonin-gene-related peptide) are produced and released triggering an airway neurogenic inflammation, characterized by plasma protein extravasation, airway smooth muscle contraction and increased mucus secretion (Fig. 1) . Neuropeptide receptors are also Sensory neurons contain irritant receptors (transient receptor potential ion channels TRPV1 and TRPA1) that release inflammatory cytokines and neuropeptides upon activation by environmental irritants. Neuropeptides are proinflammatory mediators involved in acute inflammatory responses, playing an important role in the amplification of tissue injury by the increase of bronchial constriction, vascular permeability, mucus secretion and neutrophil recruitment ('neurogenic inflammation'). Neuropeptides also interact with their receptors on both respiratory epithelial cells and immune cells, resulting in the release of cytokines that also promote airway inflammation. Disruption of the epithelial barrier lining the lumen would result in enhanced and prolonged inflammatory events and also in loss of neutral endopeptidase, an enzyme involved in the degradation of neuropeptides. Neurotrophins like nerve growth factor (NGF) have profound effects on inflammation, repair and remodeling of tissues; however, in the lung these beneficial effects can transact into disease promoting actions, for example, in allergic inflammation. Overproduction of NGF then enhances inflammation, promotes airway hyperreactivity and potentiates neurogenic inflammation.
located at various types of respiratory epithelial cells (neuroendocrine cells, Clara cells and type II alveolar cells) and immune cells, which upon activation by tachykinin neuropeptides result in the release of pro-inflammatory cytokines (e.g. IL-1b, IL-6, IL-8 and TNFa) and substances that ultimately promote and sustain the inflammatory events [33] . It has been proposed that neuropeptides may be up-regulated in asthma [34] .
The neurogenic inflammation provoked by different stimuli is regulated by neutral endopeptidase (NEP), a metallopeptidase located at the surface of airway epithelial cells that is involved in the degradation and inactivation of tachykinin neuropeptides (Fig. 1) . Factors relevant for airway diseases, such as viral infections, allergen exposure, inhalation of cigarette smoke and other respiratory irritants may reduce NEP activity, thus enhancing and perpetuating airway inflammation [35] . The disproportionate inflammatory response of two critical airway target cells (sensory C-fibers and respiratory epithelial cells) following the inhalation of chemical irritants is characterized by damage to the epithelial barrier that lines the airways. This damage not only results in the loss of critical NEP but allows the sensory fiber to physically extend closer to the airways lumen and in closer proximity to the inhaled noxious stimuli. The higher inflammatory sensitivity of sensory neurons would result in enhanced and prolonged inflammatory events [26] .
Neurotrophins are growth factors constitutively expressed by resident lung cells (epithelial cells and smooth muscle cells) and produced in increasing concentrations by immune cells, such as eosinophils, mast cells, lymphocytes and macrophages invading the airways under pathological conditions [36] . Neurotrophins control the development and function of neurons by stimulating the production of neuropeptides by airway sensory C-fibers ( Fig. 1) . Apart from this, they also induce migration and activation of both inflammatory cells infiltrating the bronchial mucosa and structural cells (i.e. epithelial, smooth muscle cells and pulmonary fibroblasts) because they all express neurotrophin receptors. Evidence from animal models has implicated nerve growth factor (NGF) as a mediator of pulmonary inflammation, bronchoconstriction, airway hyper-reactivity and airway remodeling, all of which are hallmarks of asthma [37] . Overproduction of NGF enhances inflammation, and promotes airway hyper-reactivity and neurogenic inflammation [38] . Therefore, NGF may help to understand the neuro-immune cross-talk involved in chronic inflammatory airway diseases [39] .
M2 receptor dysfunction
Organophosphate pesticide-induced asthma has been proposed to be mediated by inhibition of acetyl-cholin-esterase (AChE) [23] , the enzyme that degrades acetylcholine. However, organophosphates can produce bronchial hyper-responsiveness in the absence of AChE inhibition by causing a loss of parasympathetic prejunctional muscarinic M2 receptor function [40] . Yet neither direct pharmacologic antagonism nor down-regulated expression of M2 receptors contributes to organophosphate inhibition of M2 function in airways nerve [41 ] . These autoinhibitory receptors normally limit acetylcholine release from parasympathetic fibers and may be dysfunctional in patients with asthma, resulting in unopposed M1 and M3 activity producing excessive bronchoconstriction [42] . In animals exposed to low concentrations of organophosphate pesticides, unable to inhibit AChE activity in the lung or blood, bronchial M2 muscarinic receptor function is lost resulting in an increased basal release of acetylcholine and potentiation of bronchoconstriction [40, 43] . Because parasympathetic nerves supplying glands in the airways also regulate mucin secretion, organophosphates potentiate not only basal tone and reflex bronchoconstriction but also mucus secretion, all of which are characteristics of asthma. These are not generalized properties of all pesticides since the insecticide permethrin neither potentiates vagally induced bronchoconstriction nor inhibits M2 receptor function as organophosphates do [43] .
In guinea pigs, antigen sensitization promotes recruitment of eosinophils that cluster around airway nerves, a finding also reported in human asthma. Subsequent antigen inhalation, or viral infection, activates eosinophils causing release of major basic protein (MBP) that binds to and inhibits neuronal M2 muscarinic receptors leading to airway hyper-reactivity [40] . Allergen-sensitized guinea pigs have a lower threshold for organophosphate-induced airway hyper-reactivity and the underlying mechanism changes to become IL-5-dependent (IL-5 is a key regulator for eosinophils recruitment and activation). Thus, previous sensitization increases vulnerability to organophosphates [40] . Conversely, organophosphates may also increase proinflammatory cytokines (IFNg, TNFa, IL-1b) in the airways via stimulation of inflammatory cells that may contribute to airway hyper-reactivity by decreasing M2 receptor expression and function in nonsensitized individuals [41 ] . Recently, it has been reported that prior exposure to organophosphates and organochlorine pesticides increases the allergic potential of environmental chemical allergens in BALB/c mice by inducing an increased surface antigen expression of T cells [44 ] .
Conclusion
Pesticide aerosols or vapors may damage the airways directly or by interacting with irritant receptors in the bronchial mucosa causing release of mediators that eventually lead to persistent airway inflammation and nonspecific bronchial hyper-reactivity. The activation of TRPV1 and TRPA1 ion channels in bronchial C-sensory fibers, inflammatory cells and epithelial cells following exposure to multiple environmental chemicals, such as irritants and air pollutants including pesticides, may release chemical mediators that trigger a neurogenic inflammation. If airway inflammation is sustained over time, nonspecific bronchial hyper-reactivity may ensue leading to asthmatic symptoms. The dysregulation of neurogenic inflammation by chemical exposures is considered an important mechanism underlying irritantinduced asthma. Further studies at molecular level are needed to clarify the mechanistic role of pesticides as a risk factor for allergic and nonallergic asthma in occupational and environmentally exposed populations.
